Abbott Laboratories Q2 Adj. EPS $1.43 Beats $1.12 Estimate, Sales $11.30B Beat $10.29B Estimate

Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $1.43 per share which beat the analyst consensus estimate of $1.12 by 27.68 percent. This is a 22.22 percent increase over earnings of $1.17 per share from the same period last year. The company reported quarterly sales of $11.30 billion which beat the analyst consensus estimate of $10.29 billion by 9.82 percent. This is a 10.54 percent increase over sales of $10.22 billion the same period last year.